Overall survival (OS) and metastasis-free survival (MFS) in men with biochemically relapsed (BCR) prostate cancer after radical prostatectomy (RP) managed with deferred androgen deprivation treatment (ADT): A combined Johns Hopkins and CPDR study

Saved in:
Bibliographic Details
Published inAnnals of oncology Vol. 30; pp. v331 - v332
Main Authors Marshall, C.H., Chen, Y., Cullen, J., Rosner, I., Markowski, M., Trock, B., Eisenberger, M.
Format Journal Article
LanguageEnglish
Published 01.10.2019
Online AccessGet full text

Cover

More Information
ISSN:0923-7534
DOI:10.1093/annonc/mdz248.009